Adenosine uptake was studied in the piglet isolated perfused lung by means of the single-circulation paired-tracer dilution technique. Adenosine was efficiently taken up from the pulmonary vascular bed, and the process was potently inhibited by dipyridamole. Following uptake, adenosine was incorporated into intraceUular nudeotides, and at low perfusate concentrations, little or none of the incorporated radioactivity returned to the circulation. At higher concentrations, cellular uptake was saturable and products of intraceUular catabolism (inosine and hypoxanthine) were returned to the circulation. Perfusion of low concentrations of adenosine after inhibition of pulmonary adenosine kinase led to a proportional decrease in the retention of nucleotides and to a release of inosine and hypoxanthine. A small proportion of adenosine was metabolised extracellularly by adenosine deaminase; this activity was not released from perfused lungs and is apparently an ecto-enzyme. (Circ Res 53: 1-7, 1983) 
THE potent vascular actions of extracellular adenosine and adenine nucleotides, first evaluated by Drury and Szent-Gyorgi (1929) and Green and Stoner (1950) , have more recently become of increasing interest, since these compounds are likely to be involved in the endogenous control of blood flow (Rubio and Berne, 1969; Berne, 1980; Forrester, 1981) .
The lung regulates the biological activity of many circulating vasoactive agents, and this process is believed to be important in maintaining vascular homeostasis (Gillis and Roth, 1976) . Binet and Burstein (1950) first described the disappearance of ATP on passage through the lungs, and in subsequent studies in which radiolabeled nucleotides were infused (Smith and Ryan, 1970; Ryan and Smith, 1971; Cooper et al., 1979; Crutchley et al., 1978) , it was shown that the pulmonary bed degrades ATP -» ADP -» AMP -* adenosine via specific enzymes on the surface of capillary endothelium. The possibility of cellular uptake and metabolism of the adenosine thus formed was not, however, investigated.
The removal of adenosine from the pulmonary circulation has been reported only briefly. Early in vivo experiments (Pfleger and Schondorf, 1969; Kollassa et al., 1971 ) demonstrated that, in rats and guinea pigs, the majority of radioactivity following intravenous injection of labeled adenosine was retained by the lungs, and in a short abstract, Das et al. (1978) reported that inosine appeared in the venous effluent of isolated perfused rat lungs after infusion of adenosine. Both these processes were inhibited by the vasodilator, dipyridamole.
In this study, we have investigated in detail the fate of adenosine in the piglet isolated perfused lung, using the single-circulation, paired-tracer dilution technique (Yudilevich and Alvarez, 1967) , which allows a nondestructive estimate of perfusate-tissue exchange in a whole organ. We have also studied the subsequent intracellular and extracellular metabolism of adenosine.
Methods

Lung Isolation and Perfusion
Lungs were isolated from newborn to 2-day-old pigs (0.8-1.2 kg) from the Babraham herd as previously described (Hellewell and Pearson, 1982) . Briefly, approximately 30 minutes after a subcutaneous injection of heparin (500 units), the animal was killed and the chest was opened. The ductus arteriosus was ligated and cannulae were inserted into the pulmonary artery and into the left auricle, the latter to collect venous effluent from the pulmonary veins. The pulmonary vascular bed then was flushed through with 50 ml of warm Krebs' solution. The composition of the Krebs' solution was (NTM): NaCl, 118; KC1, 4.7; KH 2 PO«, 1.9; MgSO « , 1.9; glucose, 11.1; Na-HCO 3 , 25; CaClj, 1.3; and the pH was maintained at 7.4 by gassing with O 2 :CO 2 (95:5 by volume). The trachea then was cannulated and the lungs were excised and suspended in a water jacket at 37°C. The lungs were inflated with ~50 ml air and perfused at 37°C at 10 ml/ min with Krebs' solution containing 4.5% wt/vol Ficoll 70 as a colloid oncotic agent.
Adenosine Removal by the Lung
Experiments were started after an equilibration period of 15 minutes perfusion. A 100-^1 bolus of Krebs' solution containing 2.5 iiCi [2-3 H]adenosine (0.09-0.15 nmol) and 1 jiCi [U-CJsucrose (an extracellular marker) was rapidly injected into the pulmonary artery and 40 samples of venous effluent were collected in two-drop fractions for approximately 60 seconds. Samples were collected onto 50 ii\ of 50% trichloroaceric acid (TCA). Flow and drop rates were recorded before and after each injection. The perfusate could be changed without interruption of flow, via a three-way tap, to one containing a drug at a known concentration, and after a further equilibration period of 10-15 minutes, the procedure was repeated.
A 50-jtl aliquot of each sample of venous effluent was taken for liquid scintillation counting, and after correction for backgrounds and channel overlap, 3 H and 14 C counts in each sample were expressed as a percentage of the total injected. Dilution curves were constructed by plotting these values against sample number. Uptake of adenosine relative to sucrose from the pulmonary circulation was calculated from the recovery of each isotope using the equation: U = [1-3 H/ M C] X 100. Further 50-/zI aliquots of each sample were pooled, and the distribution of radioactivity in nucleosides and nucleotides was determined by thin layer chromatography (TLC) (see below).
To determine whether adenosine was incorporated into intracellular nucleotides following uptake, we injected 40 jiCi [2-3 H]adenosine (1.4-2.5 nmol) with [ 14 C]sucrose into the pulmonary artery, and 60 seconds after collecting 40 samples of venous effluent (i.e., 2 minutes after injection), removed the lungs from the perfusion system and immediately submersed them in liquid nitrogen. The heart and other extraneous material were removed and the lungs homogenized in 4 volumes (wt/vol) of ice-cold 5% TCA using the Ultra-Turrax (Type 18/2) homogenizer. A sample (1 ml) of homogenate was centrifuged (60 seconds at 12,000 g) to remove cell debris, and the distribution of radioactivity in the remaining supernatant was determined by TLC.
Measurement of Adenosine Metabolites
Aqueous samples of radiolabeled adenosine and its metabolites were neutralized with 5 M K 2 CO 3 and separated by TLC on silica gel-coated plastic sheets impregnated with fluorescent indicator as previously described (Pearson et al., 1978) . Samples (20 p\) of venous effluent were developed with 5 j/1 of a standard marker mixture in the solvent system of Pull and Mcllwain (1972) . R f values were as follows: ATP, ADP, AMP, and IMP, 0.00; inosine, 0.27; hypoxanthine, 0.39; adenosine, 0.46. In addition, samples of lung homogenate were developed with marker in the solvent system of Norman et al. (1974) . Rf values were: ATP, 0.03; ADP, 0.11; IMP, 0.25; AMP, 0.37; inosine, 0.50, adenosine and hypoxanthine, 0.61. After being located under ultraviolet light, spots were outlined in pencil, cut up into plastic mini-vials, and eluted with 1 ml 0.1 N HC1. Scintillation fluid (Packard Picofluor, 3 ml) was added to each vial, and radioactivity was determined in a Beckman LS 7500 liquid scintillation spectrometer.
Materials
[2-3 H]Adenosine (specific activity, 16.4-28.0 Ci/mmol) and [U-14 C]sucrose (specific activity, 382 mCi/mmol) were purchased from Amersham International, Ficoll 70 from Pharmacia, adenosine from Sigma Chemical Company, Circulation Research/Vol. 53, No. 1, July 1983 and dipyridamole (Persantin injection) from Boehringer Ingelheim Ltd. 5-Iodotubercidin and 2'-deoxycoformycin were donated by Dr. Leroy B. Townsend, University of Michigan, College of Pharmacy, Ann Arbor, Michigan, and Dr. Andrew C. Newby, Department of Cardiology, Welsh National School of Medicine, Heath Park, Cardiff, U.K., respectively. Figure 1A shows an example of dilution curves obtained after a bolus injection of [ 3 H]adenosine and [ 14 C]sucrose into lungs perfused with drug-free Krebs' solution. The C curve represents the reference dilution curve for a nonmetabolized compound of similar molecular weight to adenosine which penetrates into the extracellular space in a barrierlimited fashion. Recovery of 14 C in 40 samples was almost complete (86% in this example), and if collection was continued, all the sucrose label was recovered. The 3 H curve, however, was below the reference curve in all samples, indicating that adenosine was sequestered at a site outside the sucrose space. Recovery of 3 H in 40 samples was approximately half that of 14 C (46% in this example). Unlike dilution curves obtained after bolus injection of prostaglandin F 2a in which a tail of 3 H is observed above the 14 C curve in late samples (Hellewell and Pearson, 1982) , there was no ^H tail after bolus injection of adenosine, suggesting that most, if not all, of the 3 H that was sequestered did not return to the capillary and, therefore, was not recovered in the venous effluent. In 25 lungs perfused with drugfree Krebs' solution, overall uptake of adenosine (0.09-0.15 nmol) was 46.7 ± 2.1% (mean ± SEM). This value is a slight underestimate, since a small proportion (~10%) of the adenosine was deaminated extracellularly (see below). Figure IB shows the effect of a low concentration (10 nM) of dipyridamole on adenosine removal. Recovery of 14 C was unchanged, but that of 3 H was increased (Table 1) , and this was reflected as a decrease in overall uptake. At higher concentrations, dipyridamole completely inhibited uptake of adenosine, such that the 3 H and 14 C dilution curves were superimposed. The IC50 value (concentration required to inhibit uptake by 50%) was approximately 25 nM.
Results
Uptake of Adenosine by the Piglet Lung
The addition of unlabeled adenosine to the perfusate demonstrated that the removal process was saturable. With perfusate adenosine concentrations of 10 and 100 FIM, the recovery of 3 H increased from the control value of 45.3% to 60.4 ± 3.8% (n = 3 lungs) and 73.4 ± 2.0% (SEM) (n = 8), respectively, while recovery of 14 C was unchanged. Additionally, there was a change in the shape of the dilution curve so that, in later samples, a tail of 3 H was observed above the [ 14 C]sucrose curve, and was most apparent at 100 HM adenosine (Fig. 2) . Thus, under these conditions, in contrast to uptake in adenosine-free perfusate, uptake was followed by return of a proportion of the 3 H to the capillaries in later samples.
Intracellular Incorporation of Adenosine
The distribution of radioactivity in adenosine and its metabolites was measured in crude homogenates of lung tissue, 2 minutes after bolus injection of 40 jiCi [ 3 H]adenosine (1.4-2.5 nmol), by which time washout of radioactivity from the venous effluent was complete. Uptake of adenosine (43.1 ± 4.0%, n = 6 lungs) was not significantly different from that obtained after injection of 2.5 jtCi [ 3 H]adenosine (see Table 1 ), and approximately 95% of homoge-nate radioactivity was associated with adenine nucleotides (Table 2) .
When the perfusate was changed to one containing 5 J*M 5-iodotubercidin, an analogue of adenosine which has been documented previously as a specific inhibitor of adenosine kinase (Henderson et al., 1972) , the proportion of adenosine incorporated into nucleotides was inhibited by approximately 50% (Table 2 ). In addition, recovery of H was increased (65.3 ± 5.3%, 4 lungs), while that of 14 C was unchanged (79.8 ± 1.6), and there was a change in the shape of the 3 H dilution curve (Fig. 3 ), similar to that obtained when uptake was measured in the Values shown are means ± SEM, n = number of lungs. Significant differences from control values were revealed by analysis of variance and comparison of means: * P < 0.001. The values for adenosine uptake have not been corrected for the presence of 3 H-labeled metabolites (see Table 3 ). presence of unlabeled adenosine. Thus, inhibition of adenosine kinase also resulted in return of 3 H to the capillaries subsequent to uptake.
Analysis of Venous Effluent
Thin layer chromatography of pooled samples of effluent revealed that in control perfusions a small percentage of 3 H was consistently associated with inosine, the deaminated metabolite of adenosine (Table 3 ). The conversion did not occur in the collecting tubes, since samples were collected onto trichloroacetic acid, and in experiments in which perfusate was recirculated through lungs twice, col- lected, and then incubated at 37°C with adenosine, no measurable metabolism occurred in 60 minutes (data not shown), demonstrating that adenosine deaminase was not released into the perfusate. Inosine apparently was not a product of intracellular deamination, since the dilution curves indicated that, under control conditions, intracellular 3 H did not return to the capillaries. This was confirmed by blocking adenosine uptake with dipyridamole, which did not change the percentage of inosine formed (Table 3 ). However, conversion of adenosine to inosine was abolished when the perfusate con- tained 1 J*M 2' -deoxycoformycin, a specific inhibitor of adenosine deaminase (Agarwal et al., 1977) (Table  3) .
In some experiments, effluent was pooled in four 10-sample fractions. Figure 4 shows that in control perfusates the percentage of inosine increased approximately linearly with sample number. The observed low levels of hypoxanthine are attributable, at least in part, to contamination by adenosine in the TLC separation. In contrast, the effluent from lungs perfused with 5 HM 5-iodotubercidin contained more inosine (with a proportionately higher increment in later samples) and substantially more hypoxanthine, again particularly in later samples where the level reached approximately two-thirds that of inosine. Similar results were obtained with effluent from lungs perfused with 100 HM unlabeled adenosine (data not shown). Thus the 3 H that returned to the capillaries after adenosine uptake was found predominantly, if not exclusively, in inosine and hypoxanthine. Extracellular adenosine is believed to be an important mediator of several physiological processes. It has been proposed as a local hormone in the vasodilator response to ischemia, not only in the coronary bed (Berne, 1980) , but also in the cerebral circulation (Winn et al., 1979) and in skeletal muscle (Bockman et al., 1976) . Adenosine also inhibits blood platelet aggregation (Haslam and Rosson, 1975) and modulates neurotransmission, in addition to acting as a transmitter itself (Burnstock, 1979) . It is therefore important to understand how circulating adenosine is removed or inactivated.
Initially, inactivation of adenosine was thought to occur exclusively by deamination in plasma or in blood cells (Clarke et al., 1952) , but subsequent studies showed that the pulmonary (Pfleger and Schondorf, 1969; Kolassa et al., 1971 ) and coronary (Jacob and Berne, 1960; Kolassa et al., 1970; Liu and Feinberg, 1971; Olsson et al., 1972) vascular beds remove circulating adenosine. The fate of adenosine in the heart has been investigated extensively; from studies with isolated enzymes or involving the infusion of adenosine it was established that adenosine was incorporated into tissue nucleotides and that inosine and hypoxanthine were found in the venous effluent (Baer and Drummond, 1968; Liu and Feinberg, 1971; de Jong, 1972; Weidmeier et al., 1972; Namm, 1973) . More recently, however, there has been increasing evidence demonstrating compartmentation of cardiac nucleotides (Schrader and Gerlach, 1976; Schutz et al., 1981) and indicating the possibility that incorporation of adenosine into S-adenosylhomocysteine plays a regulatory role in cardiac tissue . Together with histochemical evidence for compartmentation of enzymes involved in coronary adenosine metabolism [e.g., the localization of nucleoside phosphorylase primarily to vascular endothelium (Mentzer et al., 1975) ], this work indicates that the fate of circulating adenosine in the coronary bed may involve several pathways, and that these may be different in different cell types (e.g., in endothelial or myocardial cells). Likewise, the source and mechanism of release of adenosine following coronary ischemia remain controversial (Berne, 1980; Nees and Gerlach, 1983) .
In contrast to the detailed studies in the heart, there has been little investigation of the fate of circulating adenosine in the pulmonary or other vascular beds. We chose to study the pulmonary metabolism of adenosine because, first, the lungs contain the largest capillary network in the body, and this has been implicated in the physiological regulation of levels of other vasoactive mediators (Gillis and Roth, 1976) , and, second, previous experiments in this laboratory (Pearson et al., 1978 (Pearson et al., , 1983 showed that porcine aortic endothelial cells in culture efficiently take up adenosine and incorporate it into intracellular nucleotides. Since procedures for the culture of pulmonary capillary endothelial cells are not yet available, although endothelial cells from pulmonary arterioles have recently been isolated (Ryan et al., 1982) , the question of whether capillary endothelium has different properties from aortic endothelium can be addressed, at present, only by using the intact capillary bed. In addition, some of the complexities of cardiac adenosine handling may be due specifically to the highly muscular nature of the tissue; the lung thus affords the opportunity to study the fate of circulating adenosine in an organ in which ATP turnover is not so rapid.
Our results show that the piglet pulmonary circulation efficiently takes up adenosine and confirm that the process is potently inhibited by dipyridamole. After the injection of trace amounts of adenosine (approximately 1-25 ^M in the bolus, diluted rapidly in the perfusate, and reaching less than a twentieth of the initial concentration in effluent samples), about half of the adenosine was extracted during a single passage and was incorporated into cellular nucleotides. The amount of adenosine removed was similar to that removed by perfused hearts from various species. With unlabeled adenosine in the perfusate, uptake of [ 3 H]adenosine from the bolus decreased, and some of the removed radioactivity returned to the perfusate after intracellular deamination and partial further catabolism by nucleoside phosphorylase to hypoxanthine. The use of the paired-tracer dilution technique, which provided an estimate of uptake every 1.5 seconds, directly demonstrated that adenosine metabolism occurred primarily intracellularly (i.e, the return of products to the circulation was delayed relative to the extracellular marker). In previous studies of adenosine metabolism in the heart, the continuous infusion method was used, which cannot yield this information. The change in the pattern of intracellular adenosine metabolism with increasing perfusate concentrations presumably was due to the saturation (and possibly substrate inhibition) of adenosine kinase before adenosine deaminase, as occurs in other mammalian tissues (Arch and Newsholme, 1978; Lum et al., 1979; Schiitz et al., 1981) . The experiments performed in the presence of 5-iodotubercidin are consistent with this conclusion, since inhibition of adenosine kinase led to the efflux of intracellularly formed inosine and hypoxanthine.
In lungs perfused with drug-free Krebs' solution, a small percentage of adenosine was deaminated. Conversion still occurred when uptake was blocked with dipyridamole and there was no detectable leaching of adenosine deaminase into the perfusate. Conversion could be virtually abolished by 2'-deoxycoformycin, a specific inhibitor of adenosine deaminase that poorly penetrates intact cells (Newby, 1981) . These results suggest that adenosine deaminase also occurs as an ecto-enzyme in the pulmonary vascular bed. There have been several other recent reports that adenosine deaminase can be found associated with membranes ( Van der Weyden and Kelly, 1976; Schrader and Bryer, 1982; Andy and Kornfeld, 1982) and certain cell types possess a membrane receptor which specifically binds exoge-Circulation Research/Vo/. 53, No. 1, July 1983 nous adenosine deaminase (Andy and Kornfeld, 1982) . It is reasonable, therefore, to speculate that the activity found in the pulmonary circulation represents membrane-bound plasma adenosine deaminase.
The site of adenosine uptake from the pulmonary circulation is not known. There are many cell types in the lung that could contribute to the metabolism of adenosine-for example the alveolar macrophage (Strauss et al., 1973) . Capillary endothelium is, however, the most obvious candidate for several reasons: it is the cell type of greatest prevalence in the lung and is present as the first interface between circulating blood and the tissue; pulmonary capillary endothelial cells have been demonstrated directly to be responsible for the metabolism of other circulating vasoactive mediators [5-hydroxytryptamine and angiotensin I (see Strum and Junod, 1972; Ryan et al., 1975) ]; aortic endothelial cells in culture take up adenosine by a dipyridamole-sensitive process and form intracellular nucleotides (Pearson et al., 1978; Dieterle et al., 1978) .
In our experiments, designed to characterize the metabolic fate of adenosine in the pulmonary bed, the flow rate (10 ml/min) was about a tenth of the cardiac output of the piglet. We appreciate that uptake of substrates at physiological flow fates will be quantitatively less than we observed (Rickaby et al., 1982; Roth, 1982) ; nonetheless the lung is the major site of adenosine removal in vivo (Kolassa et al., 1971 ). Thus we conclude that the pulmonary vascular bed can regulate the amount of circulating adenosine, released directly into the venous circulation or generated by the sequential action of ectonucleotidases on extracellular nucleotides, by several pathways. These properties could contribute significantly to the maintenance of vascular homeostasis. The further use of the paired-tracer dilution technique will help to characterize in more detail the nature of the uptake sites and kinetics of the process.
